冠状动脉阻塞风险与进行BASILICA的必要性：VIVID分类 - Suppr

Suppr

超能文献

Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.

作者信息

Tang Gilbert H L, Komatsu Ikki, Tzemach Liron, Simonato Matheus, Wolak Arik, Blanke Philipp, Dvir Danny

机构信息

Department of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA.

出版信息

EuroIntervention. 2020 Oct 9;16(9):e757-e759. doi: 10.4244/EIJ-D-20-00067.

DOI:10.4244/EIJ-D-20-00067

PMID:32364501

Abstract

摘要

相似文献

Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.

EuroIntervention. 2020 Oct 9;16(9):e757-e759. doi: 10.4244/EIJ-D-20-00067.

Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):677-689. doi: 10.1016/j.jcin.2018.01.247.

Tearing Down the Risk for Coronary Obstruction With Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):690-692. doi: 10.1016/j.jcin.2018.01.266.

Is BASILICA the Standard for Preventing Coronary Obstruction in High-Risk Transcatheter Aortic Valve Replacement?

JACC Cardiovasc Interv. 2021 May 10;14(9):949-951. doi: 10.1016/j.jcin.2021.03.028.

Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.

Eur Heart J. 2018 Feb 21;39(8):687-695. doi: 10.1093/eurheartj/ehx455.

Imaging of Aortic Valve Cusps Using Commissural Alignment: Guidance for Transcatheter Leaflet Laceration With BASILICA.

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2262-2265. doi: 10.1016/j.jcmg.2019.04.019. Epub 2019 Jun 12.

Risk of Coronary Obstruction in Transcatheter Aortic Valve Replacement.

Circ J. 2015;79(10):2100-2. doi: 10.1253/circj.CJ-15-0910. Epub 2015 Sep 9.

Commentary: Avoiding danger-Addressing the specter of coronary obstruction during transcatheter aortic valve replacement.

J Thorac Cardiovasc Surg. 2020 Mar;159(3):839-841. doi: 10.1016/j.jtcvs.2019.05.006. Epub 2019 May 23.

Anticipating coronary obstruction with three-dimensional printing in transcatheter aortic valve implantation.

EuroIntervention. 2020 Mar 20;15(16):1424-1425. doi: 10.4244/EIJ-D-19-00609.

Delayed Coronary Obstruction After TAVR: A Call for Vigilance.

J Am Coll Cardiol. 2018 Apr 10;71(14):1525-1527. doi: 10.1016/j.jacc.2018.01.067.

引用本文的文献

Evaluation of coronary heights after Bio-Bentall using Piehler technique.

Interdiscip Cardiovasc Thorac Surg. 2025 Jul 3;40(7). doi: 10.1093/icvts/ivaf150.

Sinus Sequestration After TAV-in-SAV: Optimizing CT Planning and Procedure.

JACC Case Rep. 2025 Jun 11;30(14):103614. doi: 10.1016/j.jaccas.2025.103614.

[Role of computed tomography in transcatheter coronary and structural heart disease interventions].

REC Interv Cardiol. 2024 May 9;6(3):201-212. doi: 10.24875/RECIC.M24000460. eCollection 2024 Jul-Sep.

Virtual reality for pre-procedural planning of valve-in-valve transcatheter aortic valve implantation.

Eur Heart J Digit Health. 2025 Mar 25;6(3):372-381. doi: 10.1093/ehjdh/ztaf024. eCollection 2025 May.

Comparative analysis of anatomic changes and feasibility of valve-in-valve transcatheter aortic valve replacement between Konno and Y-incision aortic root enlargement.

JTCVS Tech. 2025 Feb 14;30:32-42. doi: 10.1016/j.xjtc.2025.02.001. eCollection 2025 Apr.

Acurate Neo2 for valve-in-valve treatment of degenerated 3F Enable sutureless bioprosthetic valve in nonagenarian patient: a case report.

Eur Heart J Case Rep. 2025 Mar 11;9(3):ytaf073. doi: 10.1093/ehjcr/ytaf073. eCollection 2025 Mar.

BIO4LIFE-Surgical Aortic Valve Replacement Followed by Valve-in-Valve Transcatheter Aortic Valve Replacement for Lifetime Management of Aortic Valve Disease: Panacea or Fairytale?

J Am Heart Assoc. 2025 Mar 4;14(5):e038464. doi: 10.1161/JAHA.124.038464. Epub 2025 Feb 19.

Balloon-assisted bioprosthetic or native aortic scallop intentional laceration to prevent iatrogenic coronary artery obstruction with en face view for patients exhibiting severe calcified leaflet: a case report.

Eur Heart J Case Rep. 2024 Dec 6;8(12):ytae643. doi: 10.1093/ehjcr/ytae643. eCollection 2024 Dec.

Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.

Eur Heart J. 2024 Sep 1;45(33):3031-3041. doi: 10.1093/eurheartj/ehae303.

Transcatheter Aortic Valve Implantation to Treat Degenerated Aortic, Mitral and Tricuspid Bioprosthesis.

J Clin Med. 2024 Jan 19;13(2):592. doi: 10.3390/jcm13020592.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.

作者信息

Tang Gilbert H L, Komatsu Ikki, Tzemach Liron, Simonato Matheus, Wolak Arik, Blanke Philipp, Dvir Danny

机构信息

Department of Cardiovascular Surgery, Mount Sinai Health System, New York, NY, USA.

出版信息

EuroIntervention. 2020 Oct 9;16(9):e757-e759. doi: 10.4244/EIJ-D-20-00067.

DOI:10.4244/EIJ-D-20-00067

PMID:32364501

Abstract

摘要

相似文献

Risk of coronary obstruction and the need to perform BASILICA: the VIVID classification.

EuroIntervention. 2020 Oct 9;16(9):e757-e759. doi: 10.4244/EIJ-D-20-00067.

Transcatheter Laceration of Aortic Leaflets to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: Concept to First-in-Human.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):677-689. doi: 10.1016/j.jcin.2018.01.247.

Tearing Down the Risk for Coronary Obstruction With Transcatheter Aortic Valve Replacement.

JACC Cardiovasc Interv. 2018 Apr 9;11(7):690-692. doi: 10.1016/j.jcin.2018.01.266.

Is BASILICA the Standard for Preventing Coronary Obstruction in High-Risk Transcatheter Aortic Valve Replacement?

JACC Cardiovasc Interv. 2021 May 10;14(9):949-951. doi: 10.1016/j.jcin.2021.03.028.

Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry.

Eur Heart J. 2018 Feb 21;39(8):687-695. doi: 10.1093/eurheartj/ehx455.

Imaging of Aortic Valve Cusps Using Commissural Alignment: Guidance for Transcatheter Leaflet Laceration With BASILICA.

JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 1):2262-2265. doi: 10.1016/j.jcmg.2019.04.019. Epub 2019 Jun 12.

Risk of Coronary Obstruction in Transcatheter Aortic Valve Replacement.

Circ J. 2015;79(10):2100-2. doi: 10.1253/circj.CJ-15-0910. Epub 2015 Sep 9.

Commentary: Avoiding danger-Addressing the specter of coronary obstruction during transcatheter aortic valve replacement.

J Thorac Cardiovasc Surg. 2020 Mar;159(3):839-841. doi: 10.1016/j.jtcvs.2019.05.006. Epub 2019 May 23.

Anticipating coronary obstruction with three-dimensional printing in transcatheter aortic valve implantation.

EuroIntervention. 2020 Mar 20;15(16):1424-1425. doi: 10.4244/EIJ-D-19-00609.

Delayed Coronary Obstruction After TAVR: A Call for Vigilance.

J Am Coll Cardiol. 2018 Apr 10;71(14):1525-1527. doi: 10.1016/j.jacc.2018.01.067.

引用本文的文献

Evaluation of coronary heights after Bio-Bentall using Piehler technique.

Interdiscip Cardiovasc Thorac Surg. 2025 Jul 3;40(7). doi: 10.1093/icvts/ivaf150.

Sinus Sequestration After TAV-in-SAV: Optimizing CT Planning and Procedure.

JACC Case Rep. 2025 Jun 11;30(14):103614. doi: 10.1016/j.jaccas.2025.103614.

[Role of computed tomography in transcatheter coronary and structural heart disease interventions].

REC Interv Cardiol. 2024 May 9;6(3):201-212. doi: 10.24875/RECIC.M24000460. eCollection 2024 Jul-Sep.

Virtual reality for pre-procedural planning of valve-in-valve transcatheter aortic valve implantation.

Eur Heart J Digit Health. 2025 Mar 25;6(3):372-381. doi: 10.1093/ehjdh/ztaf024. eCollection 2025 May.

Comparative analysis of anatomic changes and feasibility of valve-in-valve transcatheter aortic valve replacement between Konno and Y-incision aortic root enlargement.

JTCVS Tech. 2025 Feb 14;30:32-42. doi: 10.1016/j.xjtc.2025.02.001. eCollection 2025 Apr.

Acurate Neo2 for valve-in-valve treatment of degenerated 3F Enable sutureless bioprosthetic valve in nonagenarian patient: a case report.

Eur Heart J Case Rep. 2025 Mar 11;9(3):ytaf073. doi: 10.1093/ehjcr/ytaf073. eCollection 2025 Mar.

BIO4LIFE-Surgical Aortic Valve Replacement Followed by Valve-in-Valve Transcatheter Aortic Valve Replacement for Lifetime Management of Aortic Valve Disease: Panacea or Fairytale?

J Am Heart Assoc. 2025 Mar 4;14(5):e038464. doi: 10.1161/JAHA.124.038464. Epub 2025 Feb 19.

Eur Heart J Case Rep. 2024 Dec 6;8(12):ytae643. doi: 10.1093/ehjcr/ytae643. eCollection 2024 Dec.

Leaflet modification before transcatheter aortic valve implantation in patients at risk for coronary obstruction: the ShortCut study.

Eur Heart J. 2024 Sep 1;45(33):3031-3041. doi: 10.1093/eurheartj/ehae303.

Transcatheter Aortic Valve Implantation to Treat Degenerated Aortic, Mitral and Tricuspid Bioprosthesis.

J Clin Med. 2024 Jan 19;13(2):592. doi: 10.3390/jcm13020592.